Outlook Therapeutics (OTLK) Stock Chart & Stock Price History → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free OTLK Stock Alerts $7.33 -0.10 (-1.35%) (As of 05:18 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Outlook Therapeutics Stock Price Performance5 Day Performance-3.30%1 Month Performance-16.23%3 Month Performance-18.84%6 Month Performance-16.02%Year-To-Date Performance-6.98%1 Year Performance-69.20% Receive OTLK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaA ‘DeFi Summer’ Projected!Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. OTLK Stock Chart for Thursday, May, 16, 2024 OTLK Chart by TradingView Outlook Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$7.40$7.43+0.41%$7.57$7.35225,179 shs$96.66 million05/14/2024$7.54$7.40-1.86%$7.76$7.29225,534 shs$96.27 million05/13/2024$7.58$7.54-0.53%$8.13$7.50400,539 shs$98.10 million05/10/2024$7.73$7.58-1.94%$7.83$7.53392,655 shs$98.64 million05/09/2024$8.00$7.73-3.37%$8.18$7.60222,655 shs$100.57 million05/08/2024$8.21$8.00-2.56%$8.26$7.81452,632 shs$104.08 million Get the Latest News and Ratings for OTLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$8.50$8.21-3.41%$8.76$8.17200,299 shs$106.81 million05/06/2024$8.60$8.50-1.16%$8.91$8.45241,223 shs$110.59 million05/03/2024$8.50$8.60+1.18%$8.88$8.52101,285 shs$111.89 million05/02/2024$8.50$8.50$8.61$8.27202,800 shs$110.59 million05/01/2024$8.92$8.50-4.71%$9.12$8.49193,903 shs$110.59 million04/30/2024$9.10$8.92-1.98%$9.29$8.81207,628 shs$116.05 million04/29/2024$8.43$9.10+7.95%$9.19$8.35172,985 shs$118.39 million04/26/2024$8.19$8.43+2.93%$8.48$8.14120,592 shs$109.67 million04/25/2024$8.20$8.19-0.12%$8.37$7.85150,455 shs$106.58 million04/24/2024$8.20$8.20$8.66$8.00239,635 shs$106.68 million04/23/2024$8.09$8.20+1.36%$8.44$8.15151,652 shs$106.68 million04/22/2024$8.17$8.09-0.98%$8.37$7.80210,621 shs$105.25 million04/19/2024$8.29$8.17-1.45%$8.63$8.00271,754 shs$106.29 million04/18/2024$8.61$8.29-3.72%$8.84$8.12234,500 shs$107.85 million04/17/2024$8.75$8.61-1.60%$9.26$8.53418,088 shs$112.02 million04/16/2024$8.62$8.75+1.51%$9.04$8.54136,746 shs$113.84 million04/15/2024$8.70$8.62-0.92%$8.79$8.44234,570 shs$112.15 million04/12/2024$9.04$8.70-3.76%$9.19$8.61267,089 shs$113.19 million04/11/2024$8.99$9.04+0.56%$9.34$8.75393,603 shs$117.64 million04/10/2024$9.26$8.99-2.92%$9.15$8.55502,927 shs$116.96 million04/09/2024$9.35$9.26-0.96%$9.98$9.03359,688 shs$120.47 million04/08/2024$9.26$9.35+0.97%$9.48$8.89247,924 shs$121.64 million04/05/2024$9.52$9.26-2.73%$9.61$9.05198,311 shs$120.47 million04/04/2024$9.12$9.52+4.39%$9.86$8.74894,973 shs$123.86 million04/03/2024$9.70$9.12-5.98%$10.21$9.00774,329 shs$118.65 million04/02/2024$10.26$9.70-5.46%$10.86$8.851.02 million shs$126.20 million04/01/2024$11.94$10.26-14.07%$12.85$10.001.18 million shs$133.51 million03/29/2024$11.94$11.94$12.70$9.361.56 million shs$155.34 million03/28/2024$9.37$11.94+27.43%$12.70$9.361.55 million shs$155.34 million03/27/2024$8.68$9.37+7.95%$10.55$8.771.47 million shs$121.90 million03/26/2024$8.51$8.68+2.00%$8.97$8.13412,805 shs$112.95 million03/25/2024$8.63$8.51-1.39%$8.93$7.70826,227 shs$110.72 million03/22/2024$7.04$8.63+22.59%$11.72$8.3020.98 million shs$112.28 million03/21/2024$6.78$7.04+3.83%$7.74$6.80277,067 shs$91.59 millionCharles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.03/20/2024$7.41$6.78-8.44%$7.46$6.74278,107 shs$88.21 million03/19/2024$7.79$7.41-4.88%$7.72$7.11202,755 shs$96.34 million03/18/2024$8.24$7.79-5.52%$8.42$7.31414,209 shs$101.28 million03/15/2024$5.73$8.24+43.80%$10.72$5.622.27 million shs$2.14 billion03/14/2024$6.46$5.73-11.33%$6.73$5.04569,045 shs$1.49 billion03/13/2024$6.99$6.46-7.58%$6.94$6.18175,992 shs$84.09 million03/12/2024$7.82$6.99-10.57%$7.69$6.40219,718 shs$90.99 million03/11/2024$7.90$7.82-1.09%$8.00$7.6749,322 shs$101.74 million03/08/2024$8.23$7.90-3.91%$8.22$7.6561,850 shs$102.86 million03/07/2024$8.10$8.23+1.56%$8.40$7.8058,772 shs$107.04 million03/06/2024$7.92$8.10+2.32%$8.40$7.9241,455 shs$105.41 million03/05/2024$8.45$7.92-6.34%$8.54$7.8085,001 shs$103.01 million03/04/2024$8.13$8.45+4.01%$8.60$8.2049,814 shs$109.99 million03/01/2024$8.74$8.13-6.98%$8.80$8.0082,616 shs$105.74 million02/29/2024$8.75$8.74-0.16%$9.00$8.7042,621 shs$113.68 million02/28/2024$8.86$8.75-1.22%$9.00$8.7031,646 shs$113.86 million02/27/2024$8.96$8.86-1.14%$9.10$8.6040,848 shs$115.27 million02/26/2024$8.77$8.96+2.14%$9.10$8.8428,713 shs$116.60 million02/23/2024$8.58$8.77+2.21%$9.20$8.6098,681 shs$114.15 million02/22/2024$8.36$8.58+2.66%$9.48$8.1968,332 shs$111.68 million02/21/2024$8.68$8.36-3.66%$8.92$8.2852,672 shs$108.79 million02/20/2024$9.03$8.68-3.92%$9.78$8.60106,717 shs$112.93 million02/19/2024$9.03$9.03$9.70$8.8294,045 shs$117.53 million02/16/2024$9.70$9.03-6.85%$9.69$8.8393,986 shs$117.53 million02/15/2024$8.41$9.70+15.35%$10.00$8.60257,552 shs$126.17 million Related Companies: Gritstone bio Stock Chart bluebird bio Stock Chart Sangamo Therapeutics Stock Chart Passage Bio Stock Chart aTyr Pharma Stock Chart Curis Stock Chart Omega Therapeutics Stock Chart Vigil Neuroscience Stock Chart AlloVir Stock Chart CEL-SCI Stock Chart Receive OTLK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OTLK) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.